Enter inventor name

Max Thiel

This inventor holds 36 USPTO granted patents, primarily in Pharmaceutical Compounds. Top assignees: Boehringer Mannheim Gmbh, C.f. Boehringer & Soehne Gmbh. Active years: 1976-1985.

USPTO Granted Patents = 36

% Patents Active = 100.0

Average Co-Inventor Count = 5.2

ph-index = 9

Forward Citations = 414(Granted Patents)

Company Filing History:

35 out of 1,164

Boehringer Mannheim Gmbh

patents

1 out of 1

C.f. Boehringer & Soehne Gmbh

patent

Years Active: 1976-1985

Loading Chart...

Areas of Expertise:

Aziridine Derivatives

Piperidine Structures

Anti-Microbial Agents

Therapeutic Compositions

Carbazolyl Compounds

Xanthine Derivatives

Blood Sugar Reducing

Cardiac Treatment

Nitropyrazole Compounds

Phenoxyalkylcarboxylic Acids

Aminopropanol Compounds

Indole Derivatives

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4517183 - N-Substituted aziridine-2-carboxylic acid derivatives (1985-05-14),

2. 4503067 - Carbazolyl-(4)-oxypropanolamine compounds and therapeutic compositions (1985-03-05),

3. 4427680 - 1,2-Dihydroquinolines connected via an oxyalkyl group with a piperidine (1984-01-24),

4. 4397848 - N-Substituted aziridine-2-carboxylic acid immunostimulant derivatives (1983-08-09),

5. 4370323 - 2-Cyanoaziridinyl-(1)-2-substituted-aziridinyl-(1)-methanes (1983-01-25),

6. 4348401 - N-Phenoxyalkylpiperidine derivatives (1982-09-07),

7. 4330549 - Coumarins connected via an oxyalkyl group with a piperidine ring having (1982-05-18),

8. 4284633 - Derivatives of xanthine (1981-08-18),

9. 4258058 - Phenoxyalkylcarboxylic acid compounds and thrombocyte-aggregation (1981-03-24),

10. 4243807 - 4-Phenoxymethyl-piperidines (1981-01-06),

11. 4229464 - Aminopropanol substituted indole compounds and compositions for the (1980-10-21),

12. 4224438 - Adenosine-5'-carboxylic acid amides (1980-09-23),

13. 4212866 - Pharmaceutically active derivatives of (1980-07-15),

14. 4172136 - 3-Nitropyrazole compounds and anti-microbial compositions (1979-10-23),

15. 4153728 - Phenoxyalkylcarboxylic acid compounds and therapeutic compositions (1979-05-08),

Title: **Max Thiel: A Pioneering Inventor from Mannheim, DE**

Introduction

Max Thiel, an accomplished inventor based in Mannheim, Germany, has made significant contributions to the field of pharmaceuticals, holding an impressive portfolio of 36 patents. His work focuses on innovative compounds that address critical health issues, particularly those related to the immune system.

Latest Patents

Among his most recent patents, Thiel has developed N-Substituted aziridine-2-carboxylic acid derivatives. This innovation includes pharmaceutical compositions that utilize a general formula integrating various radicals such as carboxyls, alkoxycarbonyls, and more. These compounds aim to combat diseases associated with a weakened immune system and exhibit promising therapeutic potential. Additionally, he has worked on carbazolyl-(4)-oxypropanolamine compounds designed to enhance treatment options in the pharmaceutical field.

Career Highlights

Thiel's career features notable associations with reputable companies, including Boehringer Mannheim GmbH and C.F. Boehringer & Soehne GmbH. His tenure at these organizations has undoubtedly influenced his innovative pursuits and shaped his expertise in drug development and patent research.

Collaborations

Collaboration has been a crucial element in Thiel's journey as an inventor. He has worked alongside esteemed colleagues such as Wolfgang Kampe and Egon Roesch, contributing to a dynamic exchange of ideas and fostering advancements in their shared field of research.

Conclusion

Max Thiel stands out as a leading inventor in Mannheim, Germany, with a remarkable track record of patents that reflect his dedication to advancing pharmaceutical sciences. His innovative achievements not only enhance medical treatments but also inspire future inventors in the realm of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]